Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-04

FDA Approved: LEFLUNOMIDE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original application for Leflunomide from Lupin Pharmaceuticals, establishing a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leflunomide (Leflunomide)

Snippet

ORIG AP for LEFLUNOMIDE (LEFLUNOMIDE)